5//SEC Filing
HALOZYME THERAPEUTICS INC 5
Accession 0001181431-05-007917
$HALOCIK 0001159036operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:35 PM ET
Size
8.0 KB
Accession
0001181431-05-007917
Insider Transaction Report
Form 5
RYNARD CAROLYN
Vice President
Transactions
- Award
Options to Purchase Common Stock
2004-10-13$2.05/sh+35,000$71,750→ 35,000 totalExercise: $2.05From: 2008-02-01Exp: 2014-10-13→ Common Stock (35,000 underlying) - Award
Options to Purchase Common Stock
2004-12-08$2.02/sh+40,067$80,935→ 40,067 totalExercise: $2.02From: 2004-12-08Exp: 2014-12-08→ Common Stock (40,067 underlying)
Footnotes (2)
- [F1]1/12 of options vest on February 1, 2008 and monthly throughout 2008 until fully vested, contingent upon continued employment with Issuer.
- [F2]Options vest over a period of 48 months, with 50% of options vesting on date of grant, and monthly thereafter until fully vested, contingent upon continued employment with Issuer.
Documents
Issuer
HALOZYME THERAPEUTICS INC
CIK 0001159036
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001159036
Filing Metadata
- Form type
- 5
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:35 PM ET
- Size
- 8.0 KB